Summit Pharmaceuticals International (Head Office: Chiyoda-ku, Tokyo; Chief Executive Officer: Katsuya Okuyama; hereinafter "SPI") has signed an exclusive distributorship agreement in Japan with EVERZOM
The AI technology firm and pharma services company are joining to help one of the country’s leading pharmaceutical firms develop a promising drug candidate.
/PRNewswire/ CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summit Pharmaceuticals.